{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:53:08Z","timestamp":1761717188981,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Forensic and Legal Medicine"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jflm.2013.06.022","type":"journal-article","created":{"date-parts":[[2013,8,6]],"date-time":"2013-08-06T09:32:04Z","timestamp":1375781524000},"page":"816-820","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Future delivery of the Drug Interventions Programme: Do the benefits justify the costs?"],"prefix":"10.1016","volume":"20","author":[{"given":"Andrew","family":"Osborne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2007","series-title":"Drug misuse and dependence: UK guidelines on clinical management","author":"Department of Health","key":"10.1016\/j.jflm.2013.06.022_bib1"},{"year":"2011","series-title":"Statistics on drug misuse: England, 2011","author":"Health and Social Care Information Centre","key":"10.1016\/j.jflm.2013.06.022_bib2"},{"year":"2011","series-title":"Statistics from the National Drug Treatment Monitoring System (NDTMS)","author":"Department of Health","key":"10.1016\/j.jflm.2013.06.022_bib3"},{"issue":"7398","key":"10.1016\/j.jflm.2013.06.022_bib4","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/bmj.326.7398.1064","article-title":"Mortality in young offenders: retrospective cohort study","volume":"326","author":"Coffey","year":"2003","journal-title":"BMJ"},{"year":"2007","series-title":"The Drug Interventions Programme (DIP): addressing drug use and offending through \u2018Tough Choices\u2019","author":"Skobdo","key":"10.1016\/j.jflm.2013.06.022_bib5"},{"year":"2011","series-title":"Crime in England and Wales 2010\/11","author":"Home Office","key":"10.1016\/j.jflm.2013.06.022_bib6"},{"year":"2007","series-title":"An introduction to the Drug Interventions Programme for treatment providers","author":"Home Office","key":"10.1016\/j.jflm.2013.06.022_bib7"},{"year":"2012","series-title":"Drug Interventions Programme. Grants to Drug Action Teams from 2007\/08 onwards","author":"Home Office","key":"10.1016\/j.jflm.2013.06.022_bib8"},{"year":"2011","series-title":"The transition to Public Health England","author":"Department of Health","key":"10.1016\/j.jflm.2013.06.022_bib9"},{"issue":"1","key":"10.1016\/j.jflm.2013.06.022_bib10","first-page":"3","article-title":"The effectiveness of coerced treatment for drug-abusing offenders","volume":"62","author":"Farabee","year":"1998","journal-title":"Federal Probation"},{"year":"2009","series-title":"The Drug Treatment Outcomes Research Study (DTORS): cost-effectiveness analysis","author":"Davies","key":"10.1016\/j.jflm.2013.06.022_bib11"},{"year":"1996","series-title":"Drugs misuse and the criminal justice system: a review of the literature","author":"Hough","key":"10.1016\/j.jflm.2013.06.022_bib12"},{"year":"2012","series-title":"Drug treatment in England: the road to recovery","author":"National Treatment Agency for Substance Misuse","key":"10.1016\/j.jflm.2013.06.022_bib13"},{"year":"2007","series-title":"Drug misuse: opioid detoxification","author":"National Institute for Health and Clinical Excellence","key":"10.1016\/j.jflm.2013.06.022_bib14"},{"key":"10.1016\/j.jflm.2013.06.022_bib15","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"3","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jflm.2013.06.022_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub3","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1016\/j.jflm.2013.06.022_bib17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/070674370605101002","article-title":"Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian Multisite Cohort of Illicit Opioid Users (OPICAN)","volume":"51","author":"Fischer","year":"2006","journal-title":"Canadian Journal of Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.jflm.2013.06.022_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drugalcdep.2009.03.020","article-title":"Comparing overdose mortality associated with methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jflm.2013.06.022_bib19","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1111\/j.1360-0443.2011.03463.x","article-title":"Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial","volume":"106","author":"Reimer","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.jflm.2013.06.022_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s004060070028","article-title":"Quality of life in psychiatry: a systematic contribution to construct validation and the development of the integrative assessment tool \u201cmodular system for quality of life\u201d","volume":"250","author":"Pukrop","year":"2000","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"5","key":"10.1016\/j.jflm.2013.06.022_bib21","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1177\/1010539511404396","article-title":"Two-year outcomes of methadone maintenance therapy at a clinic in Malaysia","volume":"24","author":"Musa","year":"2012","journal-title":"Asia-Pacific Journal of Public Health"},{"year":"2001","series-title":"NTORS after five years (National Treatment Outcome Research Study): changes in substance use, health and criminal behaviour during the five years after intake","author":"Gossop","key":"10.1016\/j.jflm.2013.06.022_bib22"},{"key":"10.1016\/j.jflm.2013.06.022_bib23","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s11136-011-0027-0","article-title":"Health-related quality of life changes associated with buprenorphine treatment for opioid dependence","volume":"21","author":"Raisch","year":"2012","journal-title":"Quality of Life Research"},{"key":"10.1016\/j.jflm.2013.06.022_bib24","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.ijnurstu.2011.03.009","article-title":"A\u00a0good quality of life under the influence of methadone: a qualitative study among opiate-dependent individuals","volume":"48","author":"De Maeyer","year":"2011","journal-title":"International Journal of Nursing Studies"},{"year":"2013","series-title":"For medical practitioners. At a glance guide to the current medical standards of fitness to drive","author":"Driver and Vehicle Licensing Agency","key":"10.1016\/j.jflm.2013.06.022_bib25"},{"key":"10.1016\/j.jflm.2013.06.022_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drugalcdep.2011.05.016","article-title":"Clinician and service user perceptions of implementing contingency management: a focus group study","volume":"119","author":"Sinclair","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jflm.2013.06.022_bib27","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.2007.06111851","article-title":"A\u00a0meta-analytic review of psychosocial interventions for substance use disorders","volume":"165","author":"Dutra","year":"2008","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jflm.2013.06.022_bib28","article-title":"Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification","volume":"4","author":"Amato","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jflm.2013.06.022_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1521-0391.2011.00185.x","article-title":"The impact of contingency management on quality of life among cocaine abusers with and without alcohol dependence","volume":"21","author":"Andrade","year":"2011","journal-title":"The American Journal on Addictions"},{"year":"2008","series-title":"Evidence of the impact of the Drug Interventions Programme \u2013 summaries and sources","author":"DIP Strategic Communications Team","key":"10.1016\/j.jflm.2013.06.022_bib30"},{"year":"2011","series-title":"Drug Interventions Programme operational handbook","author":"Home Office","key":"10.1016\/j.jflm.2013.06.022_bib31"},{"year":"2010","series-title":"Audit and risk committee meeting on 10 February 2010","author":"National Treatment Agency for Substance Misuse","key":"10.1016\/j.jflm.2013.06.022_bib32"},{"key":"10.1016\/j.jflm.2013.06.022_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldq033","article-title":"Health outcomes in economic evaluation: the QALY and utilities","volume":"96","author":"Whitehead","year":"2010","journal-title":"British Medical Bulletin"},{"issue":"1","key":"10.1016\/j.jflm.2013.06.022_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S0266462310001194","article-title":"Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions","volume":"27","author":"Cleemput","year":"2011","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"9","key":"10.1016\/j.jflm.2013.06.022_bib35","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2165\/00019053-200826090-00004","article-title":"The NICE cost-effectiveness threshold: what it is and what that means","volume":"26","author":"McCabe","year":"2008","journal-title":"PharmacoEconomics"},{"issue":"9","key":"10.1016\/j.jflm.2013.06.022_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11090","article-title":"Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation","volume":"11","author":"Connock","year":"2007","journal-title":"Health Technology Assessment"},{"issue":"1\u20133","key":"10.1016\/j.jflm.2013.06.022_bib37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.drugalcdep.2009.02.005","article-title":"The cost effectiveness of prize-based and voucher-based contingency management in a population of cocaine- or opioid-dependent outpatients","volume":"102","author":"Olmstead","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jflm.2013.06.022_bib38","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/j.1360-0443.2012.03831.x","article-title":"Health-care services utilization in substance abusers receiving contingency management and standard care treatments","volume":"107","author":"Olmstead","year":"2012","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.jflm.2013.06.022_bib39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","article-title":"A\u00a012-item short-form health survey: construction of scales and preliminary tests of reliability and validity","volume":"34","author":"Ware","year":"1996","journal-title":"Medical Care"},{"key":"10.1016\/j.jflm.2013.06.022_bib40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1057\/cpcs.2009.20","article-title":"Explaining and sustaining the crime drop: clarifying the role of opportunity-related theories","volume":"12","author":"Farrell","year":"2010","journal-title":"Crime Prevention and Community Safety"},{"year":"2012","series-title":"Charting new waters: delivering drug policy at a time of radical reform and financial austerity, April 2012","author":"UK Drug Policy Commission","key":"10.1016\/j.jflm.2013.06.022_bib41"},{"year":"2012","series-title":"Building recovery in communities: the transition to the new public health system","author":"Department of Health","key":"10.1016\/j.jflm.2013.06.022_bib42"},{"year":"2011","series-title":"Healthy lives, healthy people: update and way forward","author":"Department of Health","key":"10.1016\/j.jflm.2013.06.022_bib43"},{"year":"2012","series-title":"Improving outcomes and supporting transparency","author":"Department of Health","key":"10.1016\/j.jflm.2013.06.022_bib44"},{"key":"10.1016\/j.jflm.2013.06.022_bib45","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1360-0443.2004.00752.x","article-title":"Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS)","volume":"99","author":"Godfrey","year":"2004","journal-title":"Addiction"},{"year":"2012","series-title":"Drug strategy 2010. Reducing demand, restricting supply, building recovery: supporting people to live a drug free life. Annual review \u2013 May 2012","author":"Home Office","key":"10.1016\/j.jflm.2013.06.022_bib46"},{"year":"2011","series-title":"Police and crime commissioners \u2013 Update","author":"Home Office","key":"10.1016\/j.jflm.2013.06.022_bib47"}],"container-title":["Journal of Forensic and Legal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1752928X13001856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1752928X13001856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:06:42Z","timestamp":1761696402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1752928X13001856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S1752928X13001856"],"URL":"https:\/\/doi.org\/10.1016\/j.jflm.2013.06.022","relation":{},"ISSN":["1752-928X"],"issn-type":[{"type":"print","value":"1752-928X"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Future delivery of the Drug Interventions Programme: Do the benefits justify the costs?","name":"articletitle","label":"Article Title"},{"value":"Journal of Forensic and Legal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jflm.2013.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.","name":"copyright","label":"Copyright"}]}}